Kathleen M. Campbell, MD, joined the Division of Gastroenterology, Hepatology and Nutrition as a fellow in 2000, after completing her pediatric residency training at Cincinnati Children's Hospital Medical Center. Following the completion of her fellowship, she pursued an additional year of training in pediatric hepatology under the mentoring of Dr. William Balistreri and the physicians and surgeons of the Pediatric Liver Care Center, becoming one of the first in her specialty to obtain focused training in this field.
In 2004, Dr. Campbell was appointed assistant professor of pediatrics in the Division of Gastroenterology, Hepatology and Nutrition and the Pediatric Liver Care Center within the UC Department of Pediatrics. Her clinical and translational research interests include post-transplant renal dysfunction and genetic modifiers of disease in biliary atresia.
MD: University of Tennessee College of Medicine, Memphis, TN, 1997.
Residency: Pediatrics, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2000.
Fellowship: Pediatric Gastroenterology, Hepatology and Nutrition, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2003.
Advanced Fellowship: Pediatric Hepatology, University of Cincinnati and Cincinnati Children's Hospital Medical Center, 2004.
Certification: Pediatrics, 2000; Pediatric Gastroenterology, Hepatology and Nutrition, 2003.
Diagnosis and management of pediatric liver disease, particularly biliary atresia and other forms of neonatal cholestasis; liver transplantation and post-transplant renal dysfunction.
Gastroenterology GI, Liver Care, Liver Transplant, Liver Tumor, Autoimmune Liver Disease
Clinical and genetic determinants of calcineurin inhibitor induced post-transplant nephrotoxicity; disease modifiers in biliary atresia
Gastroenterology Hepatology and Nutrition
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Recent Increase in Incidence of Severe Acute Hepatitis of Unknown Etiology in Children is Associated with Infection with Adenovirus and Other Nonhepatotropic Viruses. The Journal of Pediatrics. 2023; 259:113439.
Customized Postoperative Therapy Improves Bile Drainage in Biliary Atresia: A Single Center Preliminary Report. Journal of Pediatric Surgery. 2023; 58:1483-1488.
Early allograft dysfunction in a pediatric liver allograft with an occult pathogenic mutation in the urea cycle. American Journal of Transplantation. 2023; 23:673-675.
Children undergoing early liver re-transplantation for primary non-function have improved survival. Pediatric Transplantation. 2022; 26:e14347.
Natural Course of Pediatric Portal Hypertension. Hepatology Communications. 2020; 4:1346-1352.
Health literacy and its association with adherence in pediatric liver transplant recipients and their parents. Pediatric Transplantation. 2020; 24:e13726.
Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes. Digestive Diseases and Sciences. 2020; 65:1239-1251.
Prospective Assessment of Ultrasound Shear Wave Elastography for Discriminating Biliary Atresia from other Causes of Neonatal Cholestasis. The Journal of Pediatrics. 2019; 212:60-65.e3.
Extracorporeal Membrane Oxygenation in a Patient with Biliary Atresia: Case and Review of Extracorporeal Life Support Organization Data. ASAIO Journal. 2018; 64:e191-e195.
Bile Duct Development and the Notch Signaling Pathway. Alagille Syndrome. : Springer Nature; Springer Nature; 2018.